Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6152211rdf:typepubmed:Citationlld:pubmed
pubmed-article:6152211lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:6152211lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:6152211lifeskim:mentionsumls-concept:C0017129lld:lifeskim
pubmed-article:6152211lifeskim:mentionsumls-concept:C0205464lld:lifeskim
pubmed-article:6152211lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:6152211pubmed:issue1lld:pubmed
pubmed-article:6152211pubmed:dateCreated1985-4-26lld:pubmed
pubmed-article:6152211pubmed:abstractTextIn order to characterize the postjunctional beta-adrenoceptors in the rat gastric fundus, we studied the influence of beta-agonists and beta-antagonists on methacholine-contracted fundus strips. The mixed beta-agonist isopropylnoradrenaline and the beta 2-selective agonist fenoterol had a concentration-dependent relaxing effect and at higher concentrations completely inhibited the methacholine-induced tone. The reputedly beta 1-selective agonist prenalterol only produced about 50% inhibition and another reputedly beta 1-selective agonist, tazolol, had almost no relaxing effect. The beta-antagonists propranolol (beta 1 + beta 2), practolol (beta 1), H35/25 (beta 2) and ICI 118,551 (beta 2) all shifted the concentration-response curves for isopropylnoradrenaline and fenoterol in a parallel way to the right, but the slope of the Schild plot was not significantly different from 1 only for the antagonism of isopropylnoradrenaline by H35/25. The relaxing effect of prenalterol was only clearly antagonized by ICI 118,551. The results suggest that postjunctional beta 1- and beta 2-adrenoceptors are present in the rat gastric fundus.lld:pubmed
pubmed-article:6152211pubmed:languageenglld:pubmed
pubmed-article:6152211pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6152211pubmed:citationSubsetIMlld:pubmed
pubmed-article:6152211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6152211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6152211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6152211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6152211pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6152211pubmed:statusMEDLINElld:pubmed
pubmed-article:6152211pubmed:monthOctlld:pubmed
pubmed-article:6152211pubmed:issn0014-2999lld:pubmed
pubmed-article:6152211pubmed:authorpubmed-author:BogaertM GMGlld:pubmed
pubmed-article:6152211pubmed:authorpubmed-author:LefebvreR ARAlld:pubmed
pubmed-article:6152211pubmed:authorpubmed-author:VerplankenP...lld:pubmed
pubmed-article:6152211pubmed:issnTypePrintlld:pubmed
pubmed-article:6152211pubmed:day30lld:pubmed
pubmed-article:6152211pubmed:volume106lld:pubmed
pubmed-article:6152211pubmed:ownerNLMlld:pubmed
pubmed-article:6152211pubmed:authorsCompleteYlld:pubmed
pubmed-article:6152211pubmed:pagination1-9lld:pubmed
pubmed-article:6152211pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6152211pubmed:meshHeadingpubmed-meshheading:6152211-...lld:pubmed
pubmed-article:6152211pubmed:meshHeadingpubmed-meshheading:6152211-...lld:pubmed
pubmed-article:6152211pubmed:meshHeadingpubmed-meshheading:6152211-...lld:pubmed
pubmed-article:6152211pubmed:meshHeadingpubmed-meshheading:6152211-...lld:pubmed
pubmed-article:6152211pubmed:meshHeadingpubmed-meshheading:6152211-...lld:pubmed
pubmed-article:6152211pubmed:meshHeadingpubmed-meshheading:6152211-...lld:pubmed
pubmed-article:6152211pubmed:meshHeadingpubmed-meshheading:6152211-...lld:pubmed
pubmed-article:6152211pubmed:meshHeadingpubmed-meshheading:6152211-...lld:pubmed
pubmed-article:6152211pubmed:meshHeadingpubmed-meshheading:6152211-...lld:pubmed
pubmed-article:6152211pubmed:meshHeadingpubmed-meshheading:6152211-...lld:pubmed
pubmed-article:6152211pubmed:meshHeadingpubmed-meshheading:6152211-...lld:pubmed
pubmed-article:6152211pubmed:meshHeadingpubmed-meshheading:6152211-...lld:pubmed
pubmed-article:6152211pubmed:meshHeadingpubmed-meshheading:6152211-...lld:pubmed
pubmed-article:6152211pubmed:year1984lld:pubmed
pubmed-article:6152211pubmed:articleTitlePharmacological characterization of the postjunctional beta-adrenoceptors in the rat gastric fundus.lld:pubmed
pubmed-article:6152211pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6152211pubmed:publicationTypeIn Vitrolld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6152211lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6152211lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6152211lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6152211lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6152211lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6152211lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6152211lld:pubmed